View of LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE

Return to Article Details LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE Download Download PDF